The NEPSE close, in your inbox

A two-minute summary after every trading day: index move, top turnover, sector leaders and broker activity. No tips, no spam.

Free · Mon–Fri around 3:30 PM · Unsubscribe anytime

Nepse Labs
Nepse Labs

Live NEPSE data, broker analysis and research tools that help Nepali investors make their own calls, not follow tips.

Imadol, Lalitpur
+977 9746660470
admin@nepselabs.com

Product

  • Live chart
  • AI Labs
  • Broker analysis
  • Market heatmap
  • Custom screener
  • Portfolio

Free tools

  • Buy / Sell calculator
  • Right & bonus
  • Dividend
  • EMI
  • SIP

Market data

  • IPO / FPO calendar
  • Dividends
  • Sector rotation
  • Mutual funds
  • Live floorsheet

Company

  • Blogs
  • News
  • Pricing
  • Courses
  • Contact

Legal

  • Privacy policy
  • Terms & conditions

Market closed · NEPSE

TradingView

Charts powered by TradingView — a charting platform for traders and investors.

NepseLabs provides market data and analysis tools for education and research. It is not investment advice or a recommendation to buy or sell any security. Investing in shares carries risk. Market data from NEPSE and CDSC.

© 2026 NepseLabs Pvt. Ltd.

nepselabs
  1. Home
  2. Stocks
  3. OMPL

OMPL — Om Megashree Pharmaceuticals Limited

737.10
+2.10 (+0.29%)
As of Nov 20, 2026
Market Cap
4.42 Ar
Float Cap
1.33 Ar
Float
30.00%
EPS (TTM)
-6.29
P/E (TTM)
-139.90
ROE (TTM)
-6.23%
Div. Yield
—

Price Chart

View all

Company Info

View all
Intro : Om Megashree Pharmaceuticals Limited is a MANUFACTURE-sector company, listed on the Nepal Stock Exchange since Apr 30, 2025.
SymbolOMPL
Full NameOm Megashree Pharmaceuticals Limited
Websitewww.ommegashreepharmaceuticals.com
Listed DateApr 30, 2025
Trading StartedMay 4, 2025
GroupG
Registration No604273604
Permitted to TradeY
Credit Rating—
Contact PersonArjun Kumar Shrestha
Emailinfo@ommegashreepharmaceuticals.com
Phone—

Fundamentals

FY 2082/2083 · Q4
View all
Valuation
  • EPS (TTM)-6.29-522.15%
  • P/E (TTM)-139.90—
  • P/B8.98—
  • BVPS98.04—
Profitability
  • ROE-6.23%—
  • ROA-2.56%—
  • Net Profit Margin-17.96%—
  • Operating Margin28.38%—
Top-line
  • Total Income—-24.30%
  • Net Profit-37,757.017-522.88%
  • Revenue CAGR (3Y)——
  • EPS CAGR (3Y)——
Financial Health
  • Debt / Equity1.61—
  • Current Ratio1.32—
  • Quick Ratio1.23—
  • Interest Coverage353.00—
Dividend
  • Dividend Yield——
  • Payout Ratio——
  • Cash Dividend——
  • Bonus Share——
Operating Metrics
  • Inventory Days103.99—
  • Asset Turnover0.14—
  • Inventory Turnover3.51—

Capitalization

View all
Capital Structure
Paid-up Capital60.00 Cr
Market Cap4.42 Ar
Float Cap1.33 Ar
Listed Shares6,000,000
Face Value100.00
Shareholding Pattern
Public30.00%
Promoter70.00%

Moving Averages

Trend anchors across short, mid, and long horizons.

View all
SMA 20798.97
SMA 50844.40
SMA 2001,091.10
EMA 12781.52
EMA 26807.48
EMA 50842.91
EMA 2001,017.50

Performance & Risk

Return quality, downside pressure, and risk-adjusted context.

View all
Sharpe-0.40
Sortino-0.40
Treynor—
CAGR—
Max Drawdown-11.02%
Alpha—
Beta—
Trend Strength50.00

Oscillators

Momentum and short-term participation signals.

View all
RSI 916.24
RSI 1421.58
RSI 2126.39
MACD Line-25.95
MACD Signal-20.97
MACD Hist-4.98

Bands & Volatility

Where price sits inside its bands, plus range and volatility signals.

View all
BB Upper848.49
BB Middle798.97
BB Lower749.44
BB Position-12%
ATR (14)23.16
ATR %3.27%
Volatility1.41%
Vol Pctile (52W)0%

Recent Candlestick Patterns

View all
  • upper rejection↔Nov 18, 2026
  • bearish breakout↓↓Nov 17, 2026
  • strong bearish candle↓↓Nov 17, 2026
  • bearish marubozu↓↓Nov 17, 2026
  • hanging man↔Nov 13, 2026
  • upper rejection↔Nov 6, 2026
  • doji↔Nov 6, 2026
  • bearish engulfing↓↓Nov 5, 2026
  • lower rejection↔Nov 4, 2026
  • doji↔Nov 4, 2026

Smart Money Concepts

View all
Phaseneutral
Range Compression24.37%
Volume Trend-49.75%
Order Blocks
Demand762.00 – 795.00
Supplymitigated801.00 – 815.00
Liquidity Targets
↑ Buy-side816.00
↓ Sell-side736.00
All-time
ATH2,167.20
From ATH-66.09%
ATL270.00
From ATL172.22%

Broker Flow

View all
Accum: 14.3 KNet -1.1 KDist: 15.3 K
Accum Amt197.34 L
Net Amt-73.70 L
Dist Amt271.03 L
Avg Buy Rate823.67
Avg Sell Rate831.47
  • #58Naasa Securities Co. Ltd.29.74 L9.5%
  • #42Sani Securities Company Ltd.19.92 L9.0%
  • #34Vision Securities Pvt. Ltd18.29 L5.8%
  • #45Imperial Securities Company Pvt. Ltd.11.82 L4.5%
  • #36Secured Securities Ltd.11.25 L3.4%
  • #6Agrawal Securities (PVT) Ltd.10.65 L2.3%
  • #1Kumari Securities Private Limited8.12 L1.7%

Corporate Actions

View all
AGMJul 12, 2026
SGM · Acquire Royal Pharmaceuticals Pvt. Ltd., Approval on Work-Actions, Decisions, Correspondence, Process/Essential Work with Concerned Regulatory Bodies, Due Diligence Audit (DDA), Approval/Transfer/Exchange of Share Swap Ratio, Approval on Final Memorandum of Understanding (MOU), Acquire Scheme, Business Scheme/Essential Other Documents, Issuance/Distribution of Shares to the Shareholders of Royal Pharmaceuticals Pvt. Ltd., Amendment on Company's Authorized, Issued/Paid-Up Capital, Share Structure, Articles/Memorandum, Authority to the Board of Directors, Book Closure and Others.
Book Close
Jul 6, 2026
AGMJan 14, 2026
10th · Financial Highlights of FY2081/82, Appointment of Auditors for the FY2082/83, Book Closure and Miscellaneous.
Book Close
Jan 6, 2026
AGMJun 20, 2025
9th · Financial Highlights of FY2080/81, Appointment of Auditors for the FY2081/82, Establishment of Board of Directors, Amendment on Articles/Memorandum, Election of Directors from Ordinary Shareholders, Book Closure and Others.
Book Close
Jun 3, 2025

Market closed · NEPSE